Medtronic will be submitting its Hugo RAS system to the FDA for urology indication in early 2025. Medical technology company Zimmer Biomet Holdings Inc. (NYSE: ZBH) develops and manufactures ...

called Hugo, which is undergoing clinical trials in the U.S. The RAS market is severely underpenetrated. As Medtronic pointed out last year, less than 5% of procedures that can be performed ...

Medtronic MDT closed at $79.99 in the last trading session, reflecting a 0.05% drop from the previous day. Broadly speaking, 2024 has not been smooth for investors in the Medical Products industry.

Matrix Asset Advisors highlighted stocks like Medtronic plc (NYSE:MDT), in the third quarter 2024 investor letter. Medtronic plc (NYSE:MDT) develops, manufactures, and distributes device-based ...

As another year draws to a close, we look at the most consequential stories and emergent themes of the year in the medical device space, from challenges surrounding cybersecurity and device ...